First evaluation of electronic prescription service

July 10, 2012 in Medications

First evaluation of electronic prescription service

(Medical Xpress) -- The first evaluation of a new system that can provide electronic transmission of prescritpions from GP practices to community pharmacies is published today in an interim report commissioned on behalf of NHS Connecting for Health Evaluation programme.

The Evaluation of the Electronic Prescrption Service (EPS) in Primary Care is is an evaluation of a system being introduced by the NHS and primary care suppliers into all primary care community pharmacies and GP practices in England.

The system aims to allow electronic transmission of from GP practices to community pharmacies, and also to enable community pharmacies to submit electronic claims for prescription items dispensed to patients to the remuneration agency, NHS Prescription Services.

The report covers the very early stages of the roll-out of the EPS programme. Researchers from the UCL School of Pharmacy, the University of Nottingham and LSE worked with seven pairs of community pharmacies and GP practices that were participating in the testing of the system, out of a population of around 10,000 community pharmacies and 8,000 GP practices.

The evaluation is due to finish at the end of 2012, with a final report in preparation for January, 2013.

Professor Nick Barber from UCL School of Pharmacy led the research and said:

“In these early stages of implementation there has been continued development and testing to produce functional systems. Now that wider roll out is happening it is likely that the adoption by GPs will be the rate limiting step. Given the current significant changes in in England, the rate of adoption is likely to depend on GPs anticipating some form of local benefit if they adopt the system”

The evaluation was commissioned on behalf of NHS Connecting for Health by the Connecting for Programme (CfHEP), based at the University of Birmingham.

More information: Download report: The Evaluation of the Electronic Prescrption Service in Primary Care (pdf)

Provided by University College London search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Medications created 40 minutes ago | popularity not rated yet | comments 0

Experts favor US approval of Merck sleeping pill (Update)

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

Medications created 23 hours ago | popularity not rated yet | comments 0

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine

The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...

Medications created May 22, 2013 | popularity not rated yet | comments 0

Succesful results in developing oral vaccine against diarrhea

The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.

Medications created May 22, 2013 | popularity not rated yet | comments 0


When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs

Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers ...

Shortage of key drug hampering U.S. efforts to control TB, report says

(HealthDay)—A shortage of a critical tuberculosis drug has hampered the efforts of health departments across the United States to contain the spread of the highly infectious lung disease, federal officials ...

Flu vaccine also linked to narcolepsy in adults, study reports

Finnish researchers unveiled new data Thursday to link the Pandemrix flu vaccine to a higher risk of the sleeping disorder narcolepsy in adults.

Heart healthy lifestyle may cut kidney disease patients' risk of kidney failure

Maintaining a heart healthy lifestyle may also help protect chronic kidney disease patients from developing kidney failure and dying prematurely, according to a study appearing in an upcoming issue of the Journal of the Am ...

Farm bill: Senate rejects GMO labeling amendment

The Senate has overwhelmingly rejected an amendment allowing states to require labeling of genetically modified foods.

Diabetes' genetic underpinnings can vary based on ethnic background, studies say

Ethnic background plays a surprisingly large role in how diabetes develops on a cellular level, according to two new studies led by researchers at the Stanford University School of Medicine.